The European Medicines Agency issued a reminder about the Jan. 1, 2010 deadline for e-CTD submissions.
The European Medicines Agency (EMEA) has issued a reminder that the electronic Common Technical Document (e-CTD) format will be mandatory for marketing authorization applications for medicinal products for human use from Jan. 1, 2010. The mandate is part of EMEA's phased introduction of e-CTDs into the centralized procedure. The agency first began accepting electronic-only submissions, with no additional requirements for paper copies, in July 2008, and on Jan. 1, 2009, EMEA strongly recommended that all submissions be electronic.
Clinical Supply Planning in Europe - Balancing Cost, Flexibility and Time
December 19th 2024The packaging and distribution of clinical supplies is a fundamental piece to the overall success of a clinical trial, and advance preparation can help establish a more efficient supply chain. Selecting the best geographical location for those activities, however, depends on the clinical trial protocol, business decisions, and even the investigational medicinal product (IMP) being studied.